Medium-term Management Plan “For your next heartbeat-Creating a movement toward tomorrow.”

We recognize that the business environment of the medical and pharmaceutical industries in which the Suzuken Group operates is changing drastically at an unexpectedly rapid pace due to various measures being implemented to curb medical costs, as well as the promotion of deregulation, the entry of other business industries, the advancement of digitalization and other factors.

The Suzuken Group has marked fiscal 2022, the final year of its medium-term growth strategy that started from fiscal 2020, as “Chapter ZERO” with its sights set on the next 10 years and its 100th anniversary, and aims to transform into a health creation enterprise that contributes to health creation for patients. Under “Chapter ZERO,” we have focused our efforts simultaneously on both structural reform of existing businesses and challenges in new areas. We have implemented various initiatives in new business areas based on the concept of “Focus on Functions” to create new businesses by combining the functions of the Group and partner companies.

In the formulation of the new medium-term management plan that starts from fiscal 2023, the Suzuken Group will become “One Team” and advance the pages of “Chapter ONE” to continue creating new value as an entity that continues to provide new solutions and hope to the changing healthcare ecosystem*1 through the realization of health creation enterprise, thereby further enhancing corporate value and contributing to solving social issues.

※1

Next-generation healthcare infrastructure that contributes to society and improves the quality and efficiency of healthcare by organically linking various peripheral businessessuch as specialized medical care, pharmaceuticals, information, and services, with the hospital as the core platform

Suzuken Group’s Medium- to Long-term Vision of “Health Creation Enterprise”

Slogan of the Medium-term Management Plan for FY2023 to FY2025

※

Next-generation healthcare infrastructure that contributes to society and improves the quality and efficiency of healthcare by organically linking various peripheral businessessuch as specialized medical care, pharmaceuticals, information, and services, with the hospital as the core platform

The three “heartbeats” produced by the Suzuken Group

Beat1 Protect the health of local residents

Expand collaboration with outside firms to establish service packages for local healthcare and local governments

Beat 2 Reduce social waste through supply and demand adjustment functions

Reduce pharmaceutical product losses and support stable supply by establishing efficient and stable distribution functions

Beat 3 Cultivate human resources that can create future value

Foster creative leadership talents who can provide a new impact on society themselves

Sending “Solutions” and “Hope” to the Ecosystem ⇒ “your”

Mechanisms Needed to Be Strengthened toward Transformation

Business Indicators of the Medium-term Management Plan

Sustainability Initiatives

In April 2022, Suzuken established the Sustainability Committee under the direct control of the CEO. We are promoting group-wide sustainability management and setting KPIs (numerical targets) to respond to key issues.

※Target companies :

Suzuken, Sanki, ASTIS, Shoyaku, Suzuken Okinawa Yakuhin, Suzuken Iwate, Nakano Yakuhin, S.D. Logi, Sanwa Kagaku Kenkyusho, UNISMILE, S-mile, S-Care Mate, Chuo Unyu, Sanki Wellbe, Kenzmedico.

Framework of the Medium-term Management Plan

During this medium-term management plan, we have positioned “Reform of existing businesses” and “Preparation for new growth businesses” as the main themes.

In particular, we aim to create value through ideas based on “Open Innovation” toward fostering growth businesses, and to integrate them with diversifying values.